Mucuna pruriens is a plant sold as seed powders and extracts for movement and reproductive health. Its clearest benefit is relief of Parkinson’s movement symptoms, not longer life or better performance in healthy adults. No healthy-longevity regimen is established. Variable drug content, interactions, digestive intolerance, serious behavioral effects with overuse, and limited long-term safety data complicate use; sourcing and monitoring cannot establish longevity benefit. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Seated/standing blood pressure and pulse | No established target; track baseline and symptoms | Dizziness/falls |
| Blood count | Laboratory component-specific reference intervals | New blood abnormalities |
| Liver enzymes and creatinine | Laboratory analyte-specific reference intervals | Organ abnormalities affecting continued use |
| Vitamin B6 | Laboratory assay-specific reference interval | Deficiency during combined treatment; baseline/periodic if carbidopa is used |
| Semen analysis, when fertility is the clinical goal | No established target; repeated standardized samples | Sperm measures; changes do not guarantee pregnancy |
| Clinician-rated movement measures (Parkinson’s disease) | Sustained function without new harms | Motor function, not healthy-longevity outcomes |
Cadence: No preventive protocol validated. Illustrative practice: symptoms at one and four weeks, after formulation changes, then every three months; laboratory rechecks at three months, then according to findings.